节点文献

CD40配体对结肠癌细胞株的体外抑制作用

The growth-inhibitory activity of CD40 ligand in colon cancer in vitro

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 吴雨岗汪良李德春张雁云

【Author】 WU Yu-gang1,WANG Liang1,LI De-chun1,ZHANG Yan-yun2(1. Department of Surgery,the First Affiliated Hospital of Soochow University,Suzhou 215006,China; 2. Shanghai Institue of Immunology,Shanghai Jiaotong University School of Medicine,Shanghai 200025,China)

【机构】 苏州大学附属第一医院普外科上海交通大学医学院上海市免疫学研究所

【摘要】 研究免疫共刺激分子CD40在结肠癌细胞株的表达及重组可溶性人CD40配体(rshCD40L)对结肠癌细胞株的体外抑制作用。采用流式细胞仪分别检测4株结肠癌细胞(HCT116、Caco-2、SW48和COLO-320)CD40分子的表达,同时利用流式细胞仪检测γ干扰素(IFN-γ)对结肠癌细胞株CD40表达的影响。MTT法检测rshCD40L对结肠癌细胞的抑制作用,TUNEL法检测rshCD40L对结肠细胞的促凋亡作用,同时检测联合rshCD40L和IFN-γ抗结肠癌作用。结果流式细胞仪检测有3株结肠癌细胞(HCT116、Caco-2和SW48)表达CD40分子,IFN-γ能增强CD40+结肠癌细胞CD40分子的表达。rshCD40L能明显抑制CD40+结肠癌细胞的增殖作用(抑制率分别为HCT116:33.5%±5.5%;Caco-2:21.5%±3.6%;SW48:30.1%±4.2%),而对CD40-结肠癌细胞株(COLO-320)无明显抑制作用(P<0.05)。rshCD40L能诱导CD40+结肠癌细胞的凋亡作用(凋亡细胞百分比为HCT116:25.6%±4.52%;Caco-2:15.71%±2.27%;SW48:18.0%±3.7%),而对CD40-结肠癌细胞株(COLO-320)无诱导凋亡作用(P<0.05)。另外,IFN-γ能明显增强rshCD40L对结肠癌细胞的抑制增殖和促凋亡作用。重组人CD40配体与IFN-γ联合可显著诱导CD40阳性的结肠癌细胞凋亡,抑制其增殖,具有潜在的抗肿瘤作用。

【Abstract】 To investigate the expression of CD40 molecule on colon cancer cell lines and to evaluate the growth-inhibitory effect of recombinant soluble human CD40L (rshCD40L) on colon cell lines,the expression of CD40 on colon cell lines (HCT116,Caco-2,SW48,and COLO-320) and the changes induced by interferon-γ(IFN-γ) were examined by flow cytometry.The growth-inhibitory activity of rshCD40L on colon cancer cell lines was examined by MTT assay and the proportion of apoptotic tumor cells was examined with TUNEL assay. Also,the growth-inhibitory effect of the combined activity of rshCD40L and IFN-γ was examined.As demonstrated by flow cytometry,the CD40 molecules could be detected on 3 strains of colon cancer cell lines (HCT116,Caeo-2 and SW48) and the molecular expression of CD40 on these cell lines could be enhanced by the action of IFN-γ.However,the proliferative activities of these cell lines were markedly inhibited by rshCD40L molecule with the growth-inhibitory activities of 33.5±5.5% for HCT116;21.5±3.6% for Caco-2 and 30.1±4.2% for SW48 cell lines respectively. Nevertheless,no apoptosis-induced effect could be detected in another CD40+colon cancer cell line COLO320 (P<0.05).In addition,IFN-γ could significantly enhance the activities of proliferation inhibition and induction of apoptosis. From these observations,it is evident that the combined activity of rshCD40L and IFN-γ inhibit proliferation and induce apoptosis of the CD40+colon cancer cell line,and thus has a potential anti-tumor effect.

【关键词】 CD40CD40配体结肠癌增殖凋亡
【Key words】 CD40CD40Lcolon cancerproliferationapoptosis
【基金】 国家自然科学基金重点资助项目(30830109);“重大新药创制”科技重大专项(2009ZX09503-009)
  • 【文献出处】 现代免疫学 ,Current Immunology , 编辑部邮箱 ,2010年04期
  • 【分类号】R735.35
  • 【被引频次】5
  • 【下载频次】156
节点文献中: 

本文链接的文献网络图示:

本文的引文网络